← Events

The 12th Annual PDA Global Conference on Pharmaceutical Microbiology, Oct. 16-18, is designed to meet the unique needs of pharmaceutical microbiologists and interdisciplinary scientists involved in manufacturing and regulating the pharmaceutical industry.

This “best-in-class” Conference will delve into a wide variety of issues pharmaceutical microbiologists face daily and work in partnership to solve. The opening plenary session will discuss antimicrobial resistance and the crucial need to find alternative approaches to treatment.

Other topics to be covered include:

  • A U.S. FDA update on human drug compounding
  • USP updates
  • Overcoming manufacturing obstacles in combination products
  • Innovation in pharmaceutical microbiology
  • The always-popular “Ask the Regulators” session, back by popular demand!  

In addition, a microbiologist will share her personal story as a patient fighting a life-threatening battle against bacteria.

Hear about the U.S. FDA’s Mutual Reliance Initiative and its impact on pharmaceutical inspections globally, and benefit from case studies on microbial control, combination products, environmental monitoring and more.

Explore the industry’s latest technologies and trends for pharmaceutical microbiology strategies showcased in the nearly sold-out Exhibit Hall. Don’t miss the opportunity to connect with peers during refreshment breaks and the Networking Reception!

Take advantage of this exceptional learning opportunity!

Register before Aug. 4 and save up to $600.

After the Conference, attend one or more courses in the 12th Annual PDA Global Conference on Pharmaceutical Microbiology Course Series, Oct. 19-20, and expand your knowledge on microbial air samplers, bioburden and biofilm management and more. Register by Sept. 4 for the greatest savings.